BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 29977395)

  • 1. Novel unit B cryptophycin analogues as payloads for targeted therapy.
    Figueras E; Borbély A; Ismail M; Frese M; Sewald N
    Beilstein J Org Chem; 2018; 14():1281-1286. PubMed ID: 29977395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugates of modified cryptophycins and RGD-peptides enter target cells by endocytosis.
    Nahrwold M; Weiß C; Bogner T; Mertink F; Conradi J; Sammet B; Palmisano R; Royo Gracia S; Preuße T; Sewald N
    J Med Chem; 2013 Mar; 56(5):1853-64. PubMed ID: 23387527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and antitubulin activity of c10 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jan; 47(3):696-702. PubMed ID: 14736249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis and biological evaluation of fluorinated cryptophycins.
    Weiß C; Bogner T; Sammet B; Sewald N
    Beilstein J Org Chem; 2012; 8():2060-6. PubMed ID: 23209540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of RGD⁻Cryptophycin Conjugates for Targeted Drug Delivery.
    Borbély A; Figueras E; Martins A; Esposito S; Auciello G; Monteagudo E; Di Marco A; Summa V; Cordella P; Perego R; Kemker I; Frese M; Gallinari P; Steinkühler C; Sewald N
    Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 30939768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and structure determination of cryptophycins 38, 326, and 327 from the terrestrial cyanobacterium Nostoc sp. GSV 224.
    Chaganty S; Golakoti T; Heltzel C; Moore RE; Yoshida WY
    J Nat Prod; 2004 Aug; 67(8):1403-6. PubMed ID: 15332864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches for the synthesis of functionalized cryptophycins.
    Sammet B; Bogner T; Nahrwold M; Weiss C; Sewald N
    J Org Chem; 2010 Oct; 75(20):6953-60. PubMed ID: 20857920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cryptophycins as potent payloads for antibody drug conjugates.
    Verma VA; Pillow TH; DePalatis L; Li G; Phillips GL; Polson AG; Raab HE; Spencer S; Zheng B
    Bioorg Med Chem Lett; 2015 Feb; 25(4):864-8. PubMed ID: 25613677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent approaches for the synthesis of modified cryptophycins.
    Weiss C; Sammet B; Sewald N
    Nat Prod Rep; 2013 Jul; 30(7):924-40. PubMed ID: 23732943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
    J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthetic characterization and chemoenzymatic assembly of the cryptophycins. Potent anticancer agents from cyanobionts.
    Magarvey NA; Beck ZQ; Golakoti T; Ding Y; Huber U; Hemscheidt TK; Abelson D; Moore RE; Sherman DH
    ACS Chem Biol; 2006 Dec; 1(12):766-79. PubMed ID: 17240975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
    Ding Y; Seufert WH; Beck ZQ; Sherman DH
    J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Versatile Chemoenzymatic Synthesis for the Discovery of Potent Cryptophycin Analogs.
    Schmidt JJ; Khatri Y; Brody SI; Zhu C; Pietraszkiewicz H; Valeriote FA; Sherman DH
    ACS Chem Biol; 2020 Feb; 15(2):524-532. PubMed ID: 31961651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Evaluation of Linear and Macrocyclic Dolastatin 10 Analogues Containing Pyrrolidine Ring Modifications.
    Akaiwa M; Martin T; Mendelsohn BA
    ACS Omega; 2018 May; 3(5):5212-5221. PubMed ID: 30023909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis and anti-tubulin activity of epi-c3 analogues of cryptophycin-24.
    Buck SB; Huff JK; Himes RH; Georg GI
    J Med Chem; 2004 Jul; 47(14):3697-9. PubMed ID: 15214797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cephalostatin analogues--synthesis and biological activity.
    Flessner T; Jautelat R; Scholz U; Winterfeldt E
    Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of Unit A of Cryptophycin via a [2,3]-Wittig Rearrangement.
    Liang J; Hoard DW; Khau VV; Martinelli MJ; Moher ED; Moore RE; Tius MA
    J Org Chem; 1999 Mar; 64(5):1459-1463. PubMed ID: 11674204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.